On June 16, 2022, Gregory Oakes submitted his resignation from the Board of Directors of First Wave BioPharma, Inc, effective immediately. Mr. Oakes indicated that his resignation was not the result of any disagreement with the Company on any matters relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.82 USD | -4.15% | -0.35% | -32.86% |
05-20 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
05-16 | First Wave BioPharma, Inc.(NasdaqGM:ENTO) dropped from NASDAQ Composite Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.86% | 5.96M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- ENTO Stock
- News Entero Therapeutics, Inc.
- First Wave Biopharma, Inc Announces Resignation from the Board of Directors